Biocryst Pharmaceuticals (BCRX)
NASDAQ:BCRX
Holding BCRX?
Track your performance easily

BioCryst (BCRX) Financial Statements

2,137 Followers

BioCryst Financial Overview

BioCryst's market cap is currently ―. The company's EPS TTM is $-0.607; its P/E ratio is -12.81; BioCryst is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 117.08M$ 109.33M$ 92.76M$ 93.40M$ 86.74M
Gross Profit$ 113.87M$ 107.60M$ 91.37M$ 91.76M$ 85.61M
EBIT$ 11.38M$ 12.23M$ -10.51M$ -38.58M$ -8.47M
EBITDA$ 11.69M$ 12.55M$ -10.20M$ -38.16M$ -8.05M
Net Income Common Stockholders$ -14.03M$ -12.67M$ -35.38M$ -61.73M$ -36.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 330.01M$ 272.03M$ 336.55M$ 388.99M$ 397.59M
Total Assets$ 491.25M$ 472.42M$ 467.89M$ 516.96M$ 522.92M
Total Debt$ 327.36M$ 327.01M$ 322.33M$ 317.11M$ 310.24M
Net Debt$ -2.65M$ 54.98M$ -14.23M$ -71.87M$ -87.35M
Total Liabilities$ 959.82M$ 948.02M$ 944.06M$ 972.49M$ 933.91M
Stockholders Equity$ -468.56M$ -475.61M$ -476.17M$ -455.53M$ -410.99M
Cash Flow-
Free Cash Flow$ 8.19M$ -1.52M$ -53.92M$ -9.47M$ -20.88M
Operating Cash Flow$ 8.24M$ -1.37M$ -53.68M$ -8.92M$ -19.90M
Investing Cash Flow$ 8.49M$ -2.45M$ 28.76M$ -28.47M$ 23.12M
Financing Cash Flow$ 1.27M$ -1.97M$ -1.05M$ -3.17M$ 1.23M
Currency in USD

BioCryst Earnings and Revenue History

BioCryst Debt to Assets

BioCryst Cash Flow

BioCryst Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis